Arestin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7699609 ORAPHARMA Dispensing apparatus and cartridge with deformable tip
Mar, 2022

(1 year, 6 months ago)

US6682348 ORAPHARMA Dispensing apparatus and cartridge
Mar, 2022

(1 year, 6 months ago)

Arestin is owned by Orapharma.

Arestin contains Minocycline Hydrochloride.

Arestin has a total of 2 drug patents out of which 2 drug patents have expired.

Expired drug patents of Arestin are:

  • US7699609
  • US6682348

Arestin was authorised for market use on 16 February, 2001.

Arestin is available in powder, extended release;dental dosage forms.

The generics of Arestin are possible to be released after 29 March, 2022.

Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient

Market Authorisation Date: 16 February, 2001

Treatment: NA


More Information on Dosage

ARESTIN family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic